drugset / Trial / NCT02020551

Lidocaine 10% Spray Reduces Pain During Intrauterine Device Insertion

NCT02020551 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Pain during intrauterine device (IUD) insertion can be a barrier to initiation. Misoprostol and nonsteroidal drugs have found to be ineffective by clinical trials.Investigators tested whether intracervical 2% lidocaine gel decreased insertion pain compared to placebo.

Timeline

Start
2013-05
Primary completion
2013-08
Completion
—

Outcome

Met primary endpoint

paper The mean pain score during the procedure was 1.01±1.20 in the lidocaine spray group and 3.23±1.60 in the placebo spray group (p<0.001). PMID 25759418 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 10 % Topical

Indications

No indication recorded.